BREAKTHROUGH CHEMISTRY

CLEAN ENGINEERED CHEMISTRY--ZERO GIMMICKS

[BREAKTHROUGH CHEMISTRY @megolacorp]

UPDATE BKTH – Independent Lab Validation

BKTH has completed third‑party abrasion testing at ACE Laboratories using ASTM D4060 (500 g / 1,000 cycles and 1,000 g / 1,000 cycles). ACE also measured haze (ASTM D1003) and wettability change (ASTM D7334, low‑angle advancing method).

Results: ACE evaluated three configurations of the platform: a single‑pass hybrid coating, a dual‑layer hybrid system, and a dual‑layer system with an additional performance topcoat.

All three configurations demonstrated:
· Extremely low mass loss
· Minimal haze change
· Near‑zero change in wettability after abrasion
· No whitening, cracking, or delamination

These results confirm the durability and optical stability of BKTH’s next‑generation silica‑hybrid coating platform, which is protected under BKTH’s pending patent application titled “PFAS‑Free Solvent‑Based Dual‑Layer Silicon Dioxide Hybrid Coating System for Glass Substrates.

With PFAS bans now implemented across multiple countries and expanding through U.S. state‑level and federal regulation, the coatings industry is being forced into rapid reformulation. BKTH’s PFAS‑free silica‑hybrid platform directly addresses these global regulatory requirements, providing a scalable, drop‑in alternative to PFAS‑based systems across automotive, architectural, industrial, marine, electronics, appliance glass, transportation, aerospace, solar, and consumer coatings.

BKTH maintains a full PFAS‑free hybrid platform including a 120‑SKU next‑generation architecture and more than 30 legacy hybrid blends enabling compliance across multiple coating verticals. The windshield hardcoat represents only the most extreme performance challenge within this broader technology suite.

BKTH is currently engaged with multiple industry leaders evaluating PFAS‑free transitions across several of these verticals as regulatory timelines accelerate.

#BKTH#PFASFree#PFASAlternatives#NextGenCoatings#IndependentValidation#GlobalCompliance

[BREAKTHROUGH CHEMISTRY @megolacorp]

Breakthrough Chemistry, Inc. (BKTH) announces completion of a defined intellectual property transaction with CitroTech, Inc. (NYSE AM: CITR) involving fire‑retardant and fire‑prevention technology assets.
Transaction details, IP scope, retained rights, and strategic impact are outlined in the below
Full news release, https://t.co/cJR6z4TV0i

#BKTH #CITR #FireSafety #IPTransaction #SpecialtyChemistry #NYSEAM

[BREAKTHROUGH CHEMISTRY @megolacorp]

BKTH Pilot Deployment Strategy Statement
BKTH is initiating multiple field pilots across priority sustainability verticals to accelerate commercialization and real‑world validation of its U.S.-manufactured technologies.
Specifically, BKTH is initiating:

-Food digester odor and ammonia‑control pilots in Singapore
-Manure bedding and ammonia‑reduction pilots in China
-PFAS‑free and performance glass coating pilots with glass manufacturers in China

While BKTH’s products are patent-pending, designed and manufactured in the United States, the company has strategically launched these initial pilots outside the U.S. due to faster market adoption, clearer decision pathways, and lower non‑technical barriers to deployment in these regions.
Across Asia and Southeast Asia, BKTH has experienced:

-More direct access to technical decision‑makers
-Streamlined approval and pilot implementation processes
-Greater urgency around environmental performance issues, including odor control, ammonia emissions, PFAS‑free materials, and regulatory compliance
-Strong institutional support through universities, industrial partners, and government‑aligned innovation groups

For example:

-In Singapore, dense urban conditions and strict odor tolerance create immediate demand for effective food digester odor and ammonia mitigation.
-In China, dairy operations face the same ammonia and animal‑health challenges as U.S. farms.
-Glass manufacturers are rapidly adopting PFAS‑free coatings to meet evolving environmental and export standards.
-Partnerships with entities such as leading universities and industrial consortia enable rapid pilots without prolonged procurement cycles or layered business gatekeeping.

These issues: digester odor, ammonia release, PFAS elimination, and ammonia exposure in agriculture are equally present in the U.S. market. However, adoption in the U.S. often lags innovation due to:

-More complex regulatory and procurement processes
-Multi‑layered organizational decision structures
-Longer pilot approval and contracting timelines

BKTH’s international pilots are therefore not a substitution for U.S. market entry, but a de‑risking and validation strategy. By proving performance in highly demanding, real‑world environments, BKTH accelerates readiness for scaled U.S. deployment with:

Operational data Third‑party validation,
Reduced adoption risk for U.S. partners, OEMs, and regulators

BKTH expects these pilots to directly support U.S. commercial expansion, particularly in:

-Food waste digestion and organics diversion
-Dairy and agricultural emissions control
-Sustainable industrial coatings

In short, BKTH is building where implementation is fastest, so it can scale where markets are largest including the United States.

[BREAKTHROUGH CHEMISTRY @megolacorp]

NEWS UPDATE: Breakthrough Chemistry Inc. Announces PFAS Free Glass Coating Platform, Expands into Automotive Market Amid Global Regulatory Shift

BKTH debuts its PFAS‑free, multi‑layer sol‑gel glass coating platform as the industry shifts away from legacy fluorinated chemistries.

Designed for windshields and high‑wear visibility surfaces, the system pairs a chemically bonded anchor layer with a durable, optically clear topcoat for sustained performance under automotive conditions.

With global PFAS bans tightening, this platform positions BKTH at the forefront of compliant, high‑performance surface protection.

Full details https://t.co/cJR6z4TV0i

[BREAKTHROUGH CHEMISTRY @megolacorp]

Shareholder Update
We’ve received questions about visibility and liquidity, so we want to clarify our approach.

Breakthrough Chemistry is taking a modern, fundamentals‑driven path rather than the “old‑school” OTC model of hype cycles, paid campaigns, or promotional news. At this stage of our development, our focus is on building a strong foundation:
• We file all required financials and material events through OTC Markets.
• We maintain a clean balance sheet with no toxic debt or promotional liabilities.
• We publish patent pending and operational updates as they occur.
• We are directing resources toward execution, partnerships, and commercialization rather than short‑term promotional activity.
• We do expect to engage professional IR representation when it aligns with our business milestones and growth stage.

Our priority is long‑term value creation through real progress, not artificial trading activity. Liquidity tends to follow fundamentals, and we are committed to building those fundamentals the right way.

We appreciate shareholders who understand the difference between promotion and execution, and we will continue communicating as we advance our business plan.
Team BKTH

[BREAKTHROUGH CHEMISTRY @megolacorp]

Update: news release
Breakthrough Chemistry Inc. Provides Patent Pending Portfolio and Technology Platform Update to Shareholders

Platform‑Driven Commercialization Strategy--
The Company’s intellectual property portfolio currently consists of multiple patent applications pending across three master technology platforms that are supported by a flexible commercialization model based on global licensing, OEM fee structures, regional toll blending, and chemistry supply. This structure enables localized manufacturing, consistent global performance, and efficient adoption across multiple vertical markets without reliance on centralized production infrastructure

FULL release
https://t.co/cJR6z4TV0i

[BREAKTHROUGH CHEMISTRY @megolacorp]

Updated Corporate profile:
Breakthrough Chemistry, Inc. is a Nevada Corporation with its corporate office in Bonita Springs, FL and traded under the symbol BKTH on the OTCID Market.

Breakthrough Chemistry develops clean, engineered chemistry platforms designed to replace outdated, toxic, and increasingly regulated legacy chemistries. Our technologies are PFAS‑free, non‑volatile, non‑migrating, and water‑compatible, delivering measurable performance across global industrial and consumer sectors.

The company’s portfolio includes eight patents pending across three master platforms:

• Stabilized Halogen — rechargeable oxidative chemistry for odor destruction, VOC reduction, antimicrobial protection, and food safety.
• SiO₂ Surface Protection — ultra‑thin, durable silica micro‑layers that enhance clarity, repel water, resist fouling, and strengthen surfaces across transportation, marine, eyewear, agricultural, and PFAS‑free packaging applications.
• Fire‑Inhibitor Systems — water‑based fire‑inhibitor sprays for textiles, wood, carpets, foam, and flexible materials, paired with mineral‑anchored systems integrated into plastics, composites, insulation, and building materials for material‑level flame resistance.

BKTH operates a flexible, scalable business model built on global licensing, OEM fee structures, regional toll blending, and chemistry supply. This approach enables local manufacturing, consistent global performance, and straightforward adoption across multiple verticals.
https://t.co/ldQGRcBxWu

Revamp of social sites, websites in progress

[BREAKTHROUGH CHEMISTRY @megolacorp]

Update BKTH Quarterly Update (Dec 31, 2025)
Breakthrough Chemistry closed the quarter with one of the strongest financial positions in company history.

• Balance Sheet Strength
$2.25M in assets vs. $413K in liabilities, delivering $1.84M in shareholder equity. Cash increased to $57,011 from $652.

• Major IP Monetization Completed
The Company finalized the sale of its wildfire/structural fire IP:
– $100,000 cash received
– 220,000 CITR shares booked as a $1.775M current asset
– $1.46M gain recognized

• Clean, Stable Share Structure
Common shares remain tight at 9,729,304 with no dilution.
Series D Preferred reduced from 51,000 → 38,500 through cancellations and voluntary returns.

• Debt Profile Healthy
Convertible debt totals $253,608, held by insider‑aligned entities at fixed conversion prices. No toxic or variable‑rate notes.
• Platform & IP Growth

BKTH continues advancing its Stabilized Halogen, SiO₂ Surface Protection, and Fire‑Inhibitor platforms, supported by patents pending and expanding global licensing opportunities.

Breakthrough Chemistry enters 2026 with a strengthened balance sheet, a clean cap table, and scalable chemistry platforms positioned for global deployment.
#BKTH #BreakthroughChemistry #OTCMarkets #ShareholderUpdate #CleanChemistry #IPDrivenGrowth #AdvancedMaterials #PositiveEquity

[BREAKTHROUGH CHEMISTRY @megolacorp]

UPDATE — Breakthrough Chemistry Inc has taken another major step in its global expansion strategy with the execution of a new Master APAC Sales & Licensing Agreement.

BKTH has finalized an exclusive APAC Sales & Licensing Agreement with Interway International Ltd., a Hong Kong–based commercial and operational partner. Under this structure, Interway becomes BKTH’s exclusive Master APAC Agent across all sovereign APAC jurisdictions.

Interway will oversee regional sales channels, distributor onboarding, regulatory filings, warehousing, logistics, invoicing, collections, and customer support through its existing Hong Kong corporate infrastructure.
The agreement includes:
*a one‑time USD $100,000 APAC Agency Fee
*Tiered profit‑sharing
*BKTH approval rights for all sublicensing activities

“This partnership gives BKTH an immediate, fully operational APAC commercialization engine without requiring internal capital deployment,” said Robert Gardiner, President of Breakthrough Chemistry. “It accelerates our licensing strategy, expands our regional footprint, and positions our chemistry platforms for rapid adoption across multiple high‑value markets.”

Acquisition Update
BKTH has concluded its due diligence regarding the proposed acquisition of Kane & McHenry LLC dba CellHelmet and has determined the transaction will not proceed. BKTH’s investor group declined to assume potential liabilities identified during diligence.
During discussions, BKTH supplied product to CellHelmet in good faith, recording approximately $28,000 in gross revenue in 2025, while CellHelmet recorded seven‑figure sales. BKTH proposed multiple alternative commercial structures to preserve the relationship, but none were accepted.
The commercial relationship has now ended. BKTH is moving forward with new U.S. and APAC distribution pathways for its SiO₂ liquid‑glass platform and its newly developed solvent‑free polycarbonate coating designed for sunglasses, sports goggles, safety eyewear, and face shields.
https://t.co/cJR6z4TV0i
#Growth#BKTH#APACexpansion#GlobalScaling#CleanEngineeredChemistry

[BREAKTHROUGH CHEMISTRY @megolacorp]

UPDATE — CEO Transition at Breakthrough Chemistry Inc.
BKTH is implementing an important leadership transition as we enter our next phase of global expansion and commercialization.

The Board of Directors has accepted the resignation of Robert Gardiner as Chief Executive Officer. Robert will continue to serve as President and Director, focusing on supporting operations across the U.S. and Canada. His contributions have been meaningful to BKTH’s early development, and this transition reflects his desire to step back from the time‑intensive CEO role while remaining actively involved in the Company’s progress.

To support a seamless transition and strengthen our global leadership structure, the Board has appointed Sufan Siauw as the new Chief Executive Officer.
Sufan brings more than two decades of international leadership experience across manufacturing, distribution, and technology‑driven businesses. He will oversee BKTH’s next phase of global growth, licensing initiatives, and commercialization efforts.

Board Statement:
“Robert has contributed significantly to BKTH’s early development, and we appreciate his continued commitment as President and Director. As the Company expands internationally and accelerates its commercial activities, Sufan’s global experience and operational leadership make him the right executive to guide BKTH forward.”

Robert Gardiner:
“With BKTH entering a new stage of growth, this is the right time for me to transition into a role that allows me to continue supporting the Company while ensuring the CEO position is held by someone fully dedicated to the pace and scale of what comes next. I look forward to supporting Sufan and the team as BKTH expands across North America and internationally.”

Sufan Siauw:
“I am honored to step into the CEO role and lead Breakthrough Chemistry into its next chapter. The Company has built a strong foundation, and I look forward to advancing our global strategy, strengthening partnerships, and accelerating commercialization.”

https://t.co/cJR6z4TV0i
#BKTH#GROWTH#USA#ASIA-PACIFIC

[BREAKTHROUGH CHEMISTRY @megolacorp]

UPDATE:Breakthrough Chemistry Inc. (OTCID: BKTH) has released a comprehensive shareholder update detailing a transformational 2025 and outlining the Company’s strategic focus for 2026.

Highlights from the update include:
Full restructuring of legacy Medesol agreements, eliminating major debt + retiring 490M shares of potential dilution
*Additional 125M shares retired through Series D
*Completion of all FINRA actions: name/symbol change, 1:30 RS, A/S reduction
*Completion of the $1.882M GEVI IP transaction
*Progress on CellHelmet MOU discussions
*Updated SAP/Zeolite commercialization strategy across U.S. and Asia‑Pacific
*Expansion of the Hartindo fire‑inhibitor product line
*2026 focus on licensing, global distribution, and nondilutive growth initiatives

Full news release available now
https://t.co/cJR6z4TV0i

[BREAKTHROUGH CHEMISTRY @megolacorp]

UPDATE: Breakthrough Chemistry Inc (BKTH) has retired 12,500 Preferred Series D shares returned by GS Capital Blends LLC, removing 125M common‑share equivalents from potential dilution.

Company Position and Impact on Capital Structure:
-Reduces the fully diluted share exposure associated with the Series D class
-Strengthens the Company’s long‑term capitalization strategy
-Aligns GSCB’s holdings with BKTH’s
post‑reverse‑split structure
-Does not affect voting control, management, or operational direction of the Company

Notice Of Material Event
https://t.co/QPsOX8YEK2

#BKTHForward

[BREAKTHROUGH CHEMISTRY @megolacorp]

Breakthrough Chemistry Inc. (BKTH) has finalized the sale of a defined group of intellectual property assets to General Enterprise Ventures Inc. (NYSE American: CITR) in a transaction valued at $1,882,000.

“This transaction reflects some of the intrinsic value of our fire‑inhibitor platform and provides BKTH with both liquidity and long‑term equity exposure to GEVI’s commercialization strategy,” said Robert Gardiner, CEO of Breakthrough Chemistry. “We believe this strengthens our balance sheet and allows us to focus on additional IP transfers and licensees for our next generation of advanced materials and safety‑driven chemical technologies.”

The IP sold covers all structural and wildfire‑focused fire‑prevention technologies, including:
• Residential and commercial fire‑prevention solutions
• Vegetation and wildfire‑protection media
• Forest‑fire suppression blends
• Asset‑protection wildfire coatings
• Fire‑retardant coatings for structural lumber, framing, and other wood‑based building materials
• All technical manuals, formulas, design documentation, and brand assets tied to these categories

BKTH receives $100k in cash and 220,000 CITR shares and will not compete in these transferred categories within the United States, Canada, or Mexico.

BKTH continues to operate and innovate across its technology platforms, Stabilized Halogen Oxidizers, Fire Inhibitors, and SiO₂ Coatings. These platforms remain central to BKTH’s strategy, supporting ongoing development of complementary specialty chemistries at a time when demand for advanced application solutions continues to grow across multiple global markets.
#BKTH #CITR #IPTransfer #Growth

[BREAKTHROUGH CHEMISTRY @megolacorp]

BKTH is pleased to announce that the same group which recently requested the removal of our prior posts has now extended a formal offer to acquire select BKTH technology IPs. BKTH has determined the proposal aligns with our strategic objectives and is preparing to close the transaction this month. This agreement underscores the market demand for BKTH’s proprietary innovations and represents a meaningful step forward in delivering value to our shareholders.
#BKTH#StrategicPartnerships#FireSafety

[BREAKTHROUGH CHEMISTRY @megolacorp]

BKTH has removed its last two posts after being politely asked to allow time for review of potential disclosures before any further updates. We will share new developments once discussions advance.

[BREAKTHROUGH CHEMISTRY @megolacorp]

BKTH Update: Progress in Motion 🚀

We recently returned from productive meetings with K&M, where acquisition discussions and future development plans were advanced in line with our MOU timeframes. The process remains active and promising.

We trust our supportive shareholders have explored the Cellhelmet ecommerce platform and are as excited as we are about BKTH’s evolving strategy. While most of you are forward-looking and engaged, we know a few of the whiners will still ask why we haven’t made them millions overnight 😄

Rest assured: we’re building with intent, not hype. Strategic growth takes time, and we’re committed to delivering real value, not just noise.

Stay tuned. More to come.
#AwayWithTheWhiners

[BREAKTHROUGH CHEMISTRY @megolacorp]

BKTH Shareholder Update: Clarifying Communications and Expectations
We sincerely appreciate the continued interest and inquiries. That said, we’ve reached a point where repetitive questions, especially those seeking information we are legally or strategically unable to disclose are becoming counterproductive. Don’t appreciate the derogatory comments either.

Let’s be clear:
*We do not issue press releases simply to placate a handful of dissatisfied individuals.
*We do not respond to individual demands for privileged information.
*We are executing a disciplined business plan, within our means and timelines.
*We have rebuilt a defunct entity into a legitimate company with minimal debt and real operational lift.

IF you were a shareholder before our management team took control, all we expect is a simple “thank-you”. The company you invested in was defunct. Reminder, the capital from shareholders investments/ trades never enters BKTH, it is a transaction between market participants, so BKTH is not spending “your money” frivolously.

For those who joined us during this new chapter, we thank you for your patience. We are executing within our means and timelines. Our team has invested personal time, money, and discipline to transform BKTH into a legitimate, debt-light company with no management salaries and a focused, executable business plan.

If you believe in our strategy, we welcome your patience and support. If not, participation in BKTH is voluntary.

Sincerely,
BKTH Management
#BKTH#Moving Forward

[BREAKTHROUGH CHEMISTRY @megolacorp]

Breakthrough Chemistry Inc. (OTC: BKTH) has issued a new company update.
Read the full news release here: https://t.co/tLzm8YCbe4
#BKTH #OTCMarkets #CompanyUpdate #InvestorNews